Prescription drugs comprise approximately 9% of the total cost of health care in the United States. The manner in which doctors obtain information about new and changing pharmaceuticals obviously has the potential to have a profound impact on health care costs, pharmaceutical companies' profits, and the quality of health care. Patterns learned in medical school undoubtedly influence physicians' future behaviors. The authors describe an educational program, in which university pharmacists portrayed
pharmaceutical company representatives to model a promotional presentation, that they designed to generate critical thinking among third-year medical students regarding the influence of pharmaceutical representatives on the prescribing practices of physicians. The authors also provide information suggesting that the program increased the uncertainty many students felt about the accuracy and ethics of standard drug ''detailing.'' Acad. Med. 2001 ;76:1271-1277.
Prescription drugs comprise approximately 9% of the total cost of health care in the United States, but physicians who are responsible for such prescribing are frequently unaware of both the costs and the consequences, 1 and in many cases the prescriptions that are written lack adequate medical indications. Over 85% of today's prescription drugs have been introduced into clinical practice in the past 30 years: A 55year-old physician who graduated in the mid-1960s learned about only a small minority of the medicines in current use during his or her formal training. In the year 2000 alone, the Food and Drug Dr. Wilkes Administration (FDA) approved 98 new drug products. How doctors obtain the information about new and changing pharmaceuticals that will inform their choices when prescribing obviously has the potential to have a profound impact on health care costs and pharmaceutical companies' profits.
There are a variety of ways for physicians to attempt to stay current with new medicines, including reading publications in peer-reviewed and nonpeer-reviewed journals and newsletters and participating in continuing education courses. Some of these courses are funded by part of the enormous amount of money that the pharmaceutical industry spends on promotions to physicians. 2 The industry also supports ''detailing'' activities, publications, and research projects, and the distinction between promotion and education is frequently unclear. [3] [4] [5] [6] [7] Proprietary advertising frequently fails to conform to the FDA's guidelines regarding fairness and accuracy. 7, 8 There is, however, substantial evidence that promotional money is well spent, from the point of the view of the companies, because it greatly influences physicians' behaviors. 9 Even young physicians in residency training programs appear to accept a great deal of such material uncritically. 10 As directors of a medical school curriculum designed to focus on aspects of (among other things) health care economics, medical ethics, clinical pharmacology, and evidence-based medicine, we have been interested in fostering critical thinking among students. We are also keenly interested in teaching students how to access and evaluate information in the medical literature as it becomes available. Because we are aware that students and house officers interact regularly with pharmaceutical representatives, we created an educational program for students that we hoped would educate them about some elements of drug marketing, and help them to evaluate the choices they will have in dealing with proprietary interests in the future. In conjunction with this program we devised a pre-and post-program questionnaire to evaluate its impact on students' attitudes about the accuracy and ethics of standard drug detailing.
EDUCATIONAL INTERVENTION

UCLA's Doctoring Program
The University of California, Los Angeles, UCLA School of Medicine's (UCLA's) Doctoring Program 11 is a vertically and horizontally integrated longitudinal curriculum that runs through all four years of medical school. In their third year of the program, small groups of seven to eight students and two faculty tutors meet every other week to evaluate standardized cases, with a goal of promoting skills, attitudes, and knowledge in a variety of areas not traditionally addressed in the clinical portion of medical school. Key topic areas are ethics, health care economics, health services, preventive medicine, clinical pharmacology, clinical decision making, behavioral medicine, and communication skills.
All of the small-group faculty participate in a full-day training session at the beginning of the academic year and attend a one-hour faculty development session prior to the beginning of each day's three-hour group exercise. This ongoing faculty development ensures standardization and continuity in the presentation of the central educational issues of each session.
Pharmaceutical Promotion Exercise
The educational exercise was designed as a component of the Doctoring Program to address the impact of pharmaceutical manufacturers on physicians' behavior. The session was scheduled toward the very end of the academic year (June), and students were not given any advance notice of the content of the exercise. The course's faculty was informed about the program through the regular distribution of a faculty tutor guide describing the exercise in detail two weeks before the small-group session occurred. Faculty members were asked not to reveal anything about the nature of the exercise to students prior to its completion. On the day of the educational intervention small-group faculty attended a one-hour training session co-taught by the university pharmacists and one of the course directors who created the exercise. The faculty development session stressed the overall objectives of the exercise: 1. To understand the reasons for detailing pharmaceuticals to the medical profession 2. To understand potential advantages and disadvantages of pharmaceutical-medical professional interactions 3. To understand the impact of pharmaceutical promotion on health care costs 4. To discuss possible reasons in support of and against accepting gifts intended to influence prescribing behaviors 5. To understand the accuracy and honesty of information that is conveyed to physicians by pharmaceutical company detailers
The exercise itself consisted of a presentation by UCLA full-time pharmacists playing the role of a pharmaceutical representative before each of the small groups. Each pharmacist gave the eight students and two faculty members in each group (18 groups total, meeting on four separate mornings) a 20-minute talk on the virtues of a non-sedating antihistamine. The students were unaware that these ''drug reps'' were actually UCLA pharmacists.
The students were told at the outset of the session that the Doctoring Program's directors had decided that, because students would be exposed to pharmaceutical representatives on a regular basis throughout their careers, one such encounter should be presented in the Doctoring Program. They were further told that the drug reps, all of whom represented the same pharmaceutical company, would have an opportunity to make a brief presentation to the group on behalf of a very popular and aggressively marketed medication, and would then be willing to answer questions, both about the product itself and about their presentation. The drug reps brought handouts, supportive educational and promotional materials (including items such as pens and writing tablets), and a snack of bagels and cream cheese (actually provided by the Doctoring Program) to the meeting.
The five pharmacists who portrayed the drug reps were UCLA Pharmacy and Therapeutics Committee members, drug information specialists, and ambulatory and inpatient clinical pharmacists, including one individual who had previously worked as a pharmaceutical representative. The pharmacists had all previously attended two training sessions run by the course directors and pharmacy director in which institutional policies and procedures and FDA guidelines regarding pharmaceutical representatives were reviewed. The participating pharmacists had had extensive personal experience meeting with pharmaceutical representatives in the course of their duties. The pharmacists selected the medication to be detailed in the intervention (a non-sedating antihistamine) because it was one that was actively being promoted. Further, the pharmacists had seen the current marketing approaches that had been used by the pharmaceutical representatives promoting the drug. These pharmacists' experiences were collated and reviewed for conformity with overall industry tactics and standards. A presentation script was developed, with the help of the UCLA Director of Pharmaceutical Services, to allow the pharmacists to make standardized presentations to the students. The pharmacists used actual materials that had previously been given to the university's pharmacy by the man-ufacturer of the drug being ''detailed.'' The pharmacists practiced the presentations individually and together to assure that the standardized goals were accomplished and that the presentations, while deliberately designed to accent the benefits associated with the drug being promoted, sounded believable, and did not contain any outright untruths. In addition, the presentations were scripted so that each contained the following elements:
1. Anecdotal references to use by physicians at other university hospitals 2. Somewhat exaggerated (favorable) claims about toxicity and side effects 3. Claims of effectiveness citing information based on doses different from those used in common practice 4. No mention of adverse effects 5. Assertions about relative efficacy without supporting documentation 6. No information about costs 7. Reference to ''their'' product by its trade name, but to all products of potential competitors by generic name only After the ''drug rep'' finished the prepared talk, the students were encouraged to ask questions. If the following questions were not asked by students, faculty were instructed to ask how much the drug cost relative to competitors, what the side effects of the drug were compared with other drugs, and whether there had been any trials comparing the drug head-to-head with competitively marketed agents (other second-generation antihistamines). Once all questions were answered (in a standardized, reproducible manner, as well as could be anticipated) the drug reps were thanked and left the room. Students were then led through an exercise intended to critique the presentation, and specifically to address whether: Ⅲ the presentation had been balanced, Ⅲ the presentation had been accurate, Ⅲ the presenter had adequately backed up his or her claims, Ⅲ the presenter had discussed economic implications of use of the drug, Ⅲ the presenter had fairly compared the promoted drug with alternatives, Ⅲ this had been a useful educational experience, and Ⅲ the student would be more or less likely to use the drug in question after hearing the presentation.
Following this 20-minute discussion the drug rep was invited back into the classroom and reintroduced to the students as a university pharmacist and drug information consultant. The hospital pharmacists were asked to explain how their presentations reflected actual marketing strategies, as well as to point out any distortions or omissions they had made during their initial presentation.
The pharmacists talked with the students about the training and background of pharmaceutical detailers, and the process of common marketing approaches, including the use of claims and comparisons, gifts, and sponsored talks. In addition, the students explored how and why manufacturers manipulate information to benefit sales of their products. The group discussed what impact promotional activity has on health care, the impact of detailing on the costs of drugs to consumers, and possible reasons and rationales physicians give for accepting or refusing to accept gifts from manufacturers. As the last part of the exercise, the students were shown how to access unbiased, evidence-based drug information using the university hospitals' computer system. This completed the educational intervention.
Pre-Post-intervention Survey
Before the small-group sessions began, the students completed a self-administered, anonymous questionnaire containing 26 items dealing with the interface between the pharmaceutical manufacturers and the medical profession. The questionnaire had previously been pilot tested on a group of fourthyear medical students to assure that the questions were understandable and to measure the time needed to complete the instrument. The thirdyear students were asked to provide their opinions to help assess the relationship between pharmaceutical manufacturers and trainees. Specific instructions to the students read:
Recent UCLA Department policies have limited contact between pharmaceutical detailers and trainees. This policy has led to a debate in some sectors. The pharmaceutical industry contends that their activities provide an educational service to students, residents, and faculty. Others feel such practices are simply marketing strategies with no educational value. We have decided to allow representatives of several companies to come here to make a presentation to you about one of their drugs. The only other stipulation was that we be allowed to critique their talk.
Before we ask them to come in this morning, we would like to ask you a few questions about how you feel about the services they provide. Take five minutes and complete the anonymous survey.
We also administered a post-intervention survey (completed as part of a larger mandatory year-end medical school curriculum-assessment exercise). This survey took place 12 weeks after the educational session and involved a post-intervention self-administered questionnaire, which examined the same attitudes included in the pre-intervention survey.
IMPACT OF THE INTERVENTION
Full data from the questionnaires were available for 120 students (12% of the students did not complete both ques- tionnaires, because of illness, away rotations, or vacation). Group demographics and data about the types and degrees of contact between the students and pharmaceutical marketing representatives are shown in Table 1 . During the third year of medical school every member of the third-year class had received at least one gift from a pharmaceutical company, and more than a third had been given a dinner at a restaurant and free drug samples. There was no apparent difference in students' acceptance of such gifts based on gender or ethnicity.
Attitudes toward Interactions with Pharmaceutical Manufacturers
Students' attitudes toward drug company sponsorship of research, drug company-physician interactions (detailing), and drug advertisements as educational tools changed after their participation in the educational program (see Table 2 ). In each case, these changes were mostly reflected by in-creases in the numbers of students who had initially been confident that the issue in question was not problematic, but who then had become uncertain about this. For example, responses to the post-intervention questionnaire showed that, while a few more students disagreed with the statement that ''drug company sponsored research is indispensable,'' many more were unsure whether this was true. The same effect was found regarding their views about whether material presented at drug company-sponsored seminars is ''unbiased,'' whether ''such drug companysponsored research is as likely to reach negative conclusions about the company's drugs as is research from an alternative sponsor,'' whether ''when drug companies give physicians pens, calendars, or other non-educational materials, this biases the subsequent behavior of those physicians,'' and whether product information presented in drug advertisements serves an educational purpose.
The majority of students did not feel that it was unethical for physicians to interact with pharmaceutical company representatives, and this attitude was not dramatically affected by the intervention. However, more students were ''uncertain'' about every one of the issues addressed on the questionnaire after the intervention (see Tables 2 and  3 ). Very few students perceived an ethical conflict between providing the best possible care to patients and accepting small trinkets from a pharmaceutical company, and only a third found a problem with accepting free meals at a restaurant.
Attitudes toward Future Behaviors
After the educational exercise, even fewer students (25%, compared with 35% initially) felt they were sufficiently ''skilled'' to be able to critically assess claims made by pharmaceutical advertisements and promotions. Once again, this change primarily reflected an increase in the number of students who now felt ''uncertain'' in this area. Similarly, after the educational intervention, the number of students who stated they would want to have drug company representatives available to them during their residency decreased from 86% to 61%. This was not because more students felt clearly opposed to such an arrangement (only 8% at both of the assessments), but because of a concomitant increase in the number of students who felt uncertain about the desirability of such an arrangement (6% to 31%). The same pattern was evident with regard to their expectations about meeting with detailers after completion of residency training.
About one third of our students felt that voluntary guidelines would be an effective method of assuring that drug company promotional and educational activities are accurate and fairly balanced. More than three fourths felt that the FDA should aggressively punish drug companies that violate established rules regarding balance and accuracy. 
DISCUSSION
Physicians prescribe pharmaceuticals throughout their professional lives, but because new drugs are being approved and marketed so quickly, it is likely that most current medical students will ultimately prescribe a great many medicines about which they had received no training in medical school or residency. The pharmaceutical industry spends enormous amounts of money promoting its products to physicians, and pharmaceutical promotions are indeed one of the primary sources of information many physicians rely upon in making drug choices, as well as in ''learning about'' unfamiliar medications. There is evidence, however, that promotional material may not always be balanced, accurate, or fair, such that uncritical acceptance of claims made by a proprietary interest can lead to widespread prescribing patterns that are hard to justify on the basis of the medical literature. 7, 8 Habits learned in medical school may affect behaviors throughout physicians' careers, so we designed this exercise to try to encourage students to think critically when presented with promotional material from pharmaceutical companies. We designed this innovative educational exercise to challenge some non-critical beliefs already established in the minds of many thirdyear students and to lead them to question the reliability of promotional presentations.
We chose to perform the exercise, rather than merely presenting information from the literature reflecting concerns about pharmaceutical promotions, because we felt the latter approach would probably be met with skepticism. Many physicians respond with disbelief, or even hostility, when it is suggested that their judgments can be influenced or distorted by ''gifts'' and favors from industry. It is our experience that many students, likewise, feel patronized, or offended, when ''lectured to'' about ethical issues such as those raised by phy-sicians' interactions with pharmaceutical representatives (particularly when these interactions come with financial inducements attached). Although we did feel some discomfort about having hospital pharmacists pretend to be actual company representatives, we ultimately felt that this was not a major concern because students would learn the true nature of the exercise before leaving the session. Furthermore, we felt the stimulation associated with this ''live'' presentation would give us the opportunity to make an impression upon students and facilitate serious discussion of complex issues.
We made every effort to assure that the exercise itself was fair by asking the UCLA Department of Pharmacy to design a presentation that honestly reflected standard industry presentations. The pharmacists who participated had all had extensive experience with drug representatives and company promotions, and all had studied this issue extensively during their own training at UCLA. Presentations contained no demonstrably false statement about the drug being promoted, but included the types of emphases and suggestions that are commonly used to make a product seem most desirable. The participating pharmacists did bring a small amount of food for the students, but the level of ''inducements'' was very low for a promotional presentation. The pharmacists' discussions of their presentation, once the students were aware of the true nature of the exercise, stressed the subtle ways that positive attributes can be emphasized and less positive ones can be avoided or sidestepped. The presentations never suggested that promotions include lies or unethical behavior on the part of representatives.
The pre-and post-intervention results, while far from definitive, do suggest that the students' attitudes were affected by this exercise. Furthermore, the primary impact does seem to have been that the students became more uncertain about the issues raised, rather than that they adopted frankly negative beliefs or feelings. Regardless of whether the questions dealt with the accuracy of companies' promotions and presentations, the quality of sponsored research, the nature of the interaction between physicians and company representatives, or students' individual behaviors in the future, a majority of the students apparently had no concern or ethical doubt prior to the exercise, whereas a greater number of such students expressed uncertainty about the same matters three months later.
We have no idea to what extent these probable changes in attitude are durable, or whether (even in the short term) they would actually be associated with changes in behaviors. We do not believe our duty as educators, though, is to influence our students to adopt particular positions at the expense of others. Rather, our duty is to raise questions and concerns in the minds of students, and teach them to think critically-including about aspects of the ''medical culture'' into which they have been so forcefully introduced. We believe that this exercise, which raises issues medical students will have to confront throughout their careers, was successful in stimulating that process.
